Zhang Xiao-Meng, Lin Zhi-Jian, Li Fan, Zhang Bing, Guo Xiao-Xin, Yang Le
Beijing University of Chinese Medicine, Beijing 100029, China.
Center for Drug Evaluation, State Food and Drug Administration, Beijing 100045, China.
Zhongguo Zhong Yao Za Zhi. 2018 Jan;43(2):205-210. doi: 10.19540/j.cnki.cjcmm.20171106.009.
Based on the relation of efficacy and toxicity, this study mined the dosage rules and characteristics of Aconitum herbs in oral prescriptions from 48 traditional ancient books from Eastern Han dynasty to Qing dynasty, to provide the basis for strengthening the clinical risk pharmacovigilance. In the 48 traditional ancient books, 4 521 prescriptions with clear daily oral dosage were included to establish a database. SPSS 20.0 software was used for statistics and analysis of the daily dosage characteristics with different kinds of herbs, indications, dose forms, processing, use in special population, and other aspects. The results showed that 67% prescriptions contained Aconitum carmichaeli(Fuzi), and 90% of them was less than 14.87 g·d⁻¹; The dosage of A. carmichaeli(Chuanwu) and A. kusnezoffii(Caowu) were less than 3.14 g·d⁻¹. In the prescriptions for treating typhoid, epidemic, edema and phlegm, the dosage of Aconitum was larger. There dosage in the decoction and vinum was significantly higher than that in the pill and powder. With the dynastic evolution, the dosage of Aconitum herbal medicines prescriptions and the application percentage of superposition drug also had decreased. For the special populations that with different metabolism process, such as old people, children, pregnant and lactating women, the application of Aconitum was not only with relatively small ratio, but also with lower dose. Therefore, based on the data-mining of ancient books, the dosage of Aconitum should not exceed the limit prescribed by the current China Pharmacopoeia, and also should be strictly controlled by considering various factors, which will ensure the balance of efficacy and toxicity.
基于功效与毒性的关系,本研究挖掘了东汉至清代48部传统古籍中含乌头类药材的口服方剂的用量规律及特点,为加强临床用药风险的药物警戒提供依据。纳入48部传统古籍中4521首有明确每日口服剂量的方剂建立数据库,运用SPSS 20.0软件对不同种类药材、适应证、剂型、炮制、特殊人群用药等方面的每日用量特点进行统计分析。结果显示,67%的方剂含附子,其中90%的用量小于14.87g·d⁻¹;川乌、草乌用量小于3.14g·d⁻¹。治疗伤寒、疫疠、水肿、痰证的方剂中乌头类药材用量较大,汤剂和酒剂中的用量显著高于丸剂和散剂。随着朝代演变,乌头类药材方剂用量及叠加用药应用比例均呈下降趋势。对于老年人、儿童、孕妇及哺乳期妇女等代谢过程不同的特殊人群,乌头类药材不仅应用比例相对较小,用量也较低。因此,基于古籍数据挖掘,乌头类药材用量不应超过现行《中国药典》规定的限度,还应综合考虑各种因素严格控制用量,以确保功效与毒性的平衡。